Capillary Biomedical has raised $2.9 million in a seed financing and hopes to bring its technology to market in 2019.
News & Features
FDA has raised concerns about laser and energy-based devices that are being marketed for vaginal rejuvenation without adequate evidence to support the use of these devices for that purpose.
Some doctors now require patients to record a video of themselves taking their pills for the sake of proving medication adherence. One telehealth expert has concerns about this practice and doesn't see it sticking.
IBM's senior VP of cognitive solutions and IBM research defended the company's progress on bringing the benefits of AI to healthcare after recent media reports cast a negative light on the technology.
The Austin, TX-based company has been awarded a grant for nearly $3 million from the Department of Defense to develop its drug-delivery device.
FibreTuff plans to develop cellulose-based biomaterials that can be used to 3D print Class I and II medical devices for spine, trauma, and sports medicine.
Medtech companies could see continued scrutiny of customer relationships as well as of their dealings with FDA, an expert tells MD+DI.
Faced with declining sales and another Nellix delay, Endologix CEO John Onopchenko said it's time for a strategic reset.
The EndoBarrier has faced numerous issues over the past few years and has even had its CE mark taken away and its first pivotal study in the U.S. halted.
Medical devices are getting smaller, less invasive, and more advanced, an expert tells MD+DI. Read on for the latest details on trends, materials, and manufacturing.
Portable oxygen device maker Inogen expects to have 500 Cleveland-based employees by the end of 2020. What is driving the company's growth, and why did the company choose to hang its hat in the city that rocks?